Libya Parliament Speaker to Asharq Al-Awsat: We Back Political Solution, but After Tripoli Liberation

Speaker of the Libyan parliament Aguila Saleh. (Reuters)
Speaker of the Libyan parliament Aguila Saleh. (Reuters)
TT

Libya Parliament Speaker to Asharq Al-Awsat: We Back Political Solution, but After Tripoli Liberation

Speaker of the Libyan parliament Aguila Saleh. (Reuters)
Speaker of the Libyan parliament Aguila Saleh. (Reuters)

Speaker of the Libyan parliament Aguila Saleh slammed the agreement signed between Turkey and the Government of National Accord (GNA).

Speaking to Asharq Al-Awsat from Cairo after a visit to Greece, he revealed that his Greek counterpart expressed to him Athens’ rejection of the accord. Cyprus has also expressed similar angry objections, noting that Libya and Turkey do not share a marine border.

The Libyan parliament has not ratified the deal, continued Saleh.

“Turkey has taken advantage of the situation in our country and attempted to seize our state resources,” he charged. “The international community understands our position.”

“There are no legal grounds for the deal and the economic zone that extends 200 miles off the Libyan coast has been mapped out by the United Nations,” he added.

Ankara and the GNA signed last month a memorandum of understanding on military and security cooperation and another on the restriction of maritime jurisdiction, drawing criticism from the Libyan National Army, Cyprus, Greece, Egypt and Europe.

Asked about the upcoming international conference on Libya set for Berlin, Saleh said: “The meeting is aimed at unifying the European stance on the Libyan crisis, not imposing solutions on the people from abroad.”

He confirmed that he had received an invitation to visit Washington, predicting that it will likely take place in January.

“This reveals its recognition of the legitimacy of the parliament,” said Saleh, adding that he will discuss with American officials means to restore the authority of the state and build its institutions.

On the Presidential Council, which is headed by GNA chief Fayez al-Sarraj, Saleh said the body is illegal because it was never approved by the parliament.

The Council was overthrown by the militias that do not recognize it, he added.

Asked if he believes that Ankara may dispatch troops to Libya to back Sarraj, Saleh replied that it would be difficult for Turkish troops to arrive to the West, whether by sea or air. He explained that Greece has blocked Turkey’s way forward by sea and the LNA controls strategic positions in the capital, Tripoli.

On coordination with Cairo, he said that Egypt and its president Abdul Fattah al-Sisi have repeatedly expressed their support for the parliament and LNA. This support is ongoing through Sisi’s contacts with world leaders.

“We are also in constant contact because any threat to Libya will affect Egypt and all neighboring countries,” he remarked.

Moreover, Saleh said that the first step towards reaching a political solution in Libya lies in liberating Tripoli from the clutches of militias and foreign mercenaries. This will then be followed by dialogue.

He revealed that the parliament had formed a committee to hold Libyan dialogue that will draft the political solution “because the people will not accept foreign solutions.”

A new government will be formed after the dialogue, followed by the drafting of a new constitution ahead of staging of parliamentary and presidential elections, he went on to say.

“The entire Libyan people stand by us and reject the illegal policies that have been adopted by the Presidential Council,” he told Asharq Al-Awsat.

“We back the political path and reconciliation, but only after Tripoli’s liberation,” he stressed.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.